Skip to main content

Bayer, Rosetta Green Reach Deal to Improve Cotton Yields

NEW YORK (GenomeWeb News) – Rosetta Green and Bayer CropScience have signed an agreement directed at discovering and characterizing microRNA genes with the potential to improve cotton yields.

Specifically, the licensing deal announced today is directed at developing new cotton varieties that can produce improved yields under difficult environment, such as drought.

Bayer will have an exclusive license to targets identified by the collaboration toward better yields in cotton. Bayer will provide Rosetta development and commercialization milestone payments, as well as royalties based on future revenues from sales that could reach the tens of millions of dollars, the two firms said.

"We are hopeful that the new technology that Bayer and Rosetta Green will develop will succeed in significantly increasing cotton yields, especially in periods of drought and water shortage and in countries that suffer from chronic scarcity in potable water," Rosetta Green's CEO Amir Avniel said in a statement.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.